Manic symptoms induced by olanzapine

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Lefteris LykourasE Angelopoulos

Abstract

We present the case of a never medicated patient with a diagnosis of DSM-IV paranoid schizophrenia in which olanzapine therapy induced manic symptoms. The latter remitted after drug discontinuation.

References

Nov 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·R C YoungD A Meyer
Nov 5, 1997·Biological Psychiatry·J R StevensP Szot
Feb 25, 1998·Journal of the American Academy of Child and Adolescent Psychiatry·J A London
Jul 22, 1998·The Journal of Clinical Psychiatry·J P Lindenmayer, R Klebanov

❮ Previous
Next ❯

Citations

May 1, 2001·Yeast·C CompagnoD Porro
Feb 7, 2002·Pharmacoepidemiology and Drug Safety
Jul 27, 2002·Psychopharmacology·Y GüzelcanW F Scholte
Jan 31, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Panayiota G Michalopoulou, Lefteris Lykouras
Feb 21, 2006·European Psychiatry : the Journal of the Association of European Psychiatrists·R M JonesI Bitter
Jan 23, 2009·The Cochrane Database of Systematic Reviews·Andrea CiprianiJohn Geddes
Feb 28, 2003·Psychopharmacology·Paolo BrambillaJair C Soares

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Related Papers

The Journal of Clinical Psychiatry
Brock P Nolan, Jerome J Schulte
The American Journal of Psychiatry
Vidya Sundararajan, Ashok K Jainer
The Australian and New Zealand Journal of Psychiatry
Isabella PacchiarottiRoberto Tatarelli
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Lefteris LykourasJohn Hatzimanolis
© 2021 Meta ULC. All rights reserved